Scorpion Envenomation Epidemiology and Management

Scorpion envenomation continues to pose a considerable public health challenge in many tropical and subtropical regions, with an estimated one million stings and several thousand fatalities each year. Incidence is highest in areas where medically significant species of the family Buthidae overlap densely populated regions, often compounded by limited access to timely medical care. Clinical manifestations range from localised pain and paraesthesia to severe systemic effects including cardiogenic shock, pulmonary oedema and multiple organ dysfunction. Vulnerable populations such as young children and rural workers are at greatest risk of severe outcomes. Management strategies combine prompt symptomatic treatment, supportive care (including cardiorespiratory support), and administration of specific antivenoms. Ongoing efforts focus on improving epidemiological surveillance, refining antivenom formulations for broader cross-reactivity, and identifying biomarkers to guide clinical decision-making. Integrating molecular insights into toxin action with public health measures remains key to reducing morbidity and mortality worldwide.

Research from Nature Portfolio

Recent studies have elucidated the pivotal role of lipid mediators in the inflammatory response to scorpion venom. Investigations into Tityus serrulatus envenomation reveal that venom-induced activation of the NLRP3 inflammasome drives interleukin-1β release, leading to pulmonary oedema and fatal outcomes. A dynamic balance between leukotriene B4 (LTB4) and prostaglandin E2 (PGE2) was shown to govern the extent of inflammasome activation, with exogenous LTB4 attenuating venom-induced mortality. These mechanistic insights suggest that modulation of cyclo-oxygenase pathways may offer an effective adjunct to antivenom therapy in severe cases.

Scorpion Envenomation Epidemiology and Management publication trend

The graph below shows the total number of articles in scorpion envenomation epidemiology and management across all publications each year (not limited to Nature Index journals).

Technical terms

Inflammasome: A multiprotein complex in immune cells that activates pro-inflammatory cytokines in response to pathogen- or damage-associated signals.

Lipid mediators (LTB4, PGE2): Bioactive lipids that modulate immune responses; leukotriene B4 drives chemotaxis, whereas prostaglandin E2 regulates vascular permeability and cytokine release.

Voltage-gated sodium channel: Transmembrane protein in excitable tissues that initiates and propagates action potentials; a principal target of scorpion neurotoxins.

Middle-mass molecules (MMMs): Endogenous peptides and proteins of intermediate molecular weight that serve as markers of organ injury and systemic toxin burden.

Whole-cell patch-clamp electrophysiology: An experimental technique for measuring ionic currents through cell membranes, utilised to quantify venom neutralisation by antivenom preparations.

References

1. Taking the sting out of scorpions: Electrophysiological investigation of the relative efficacy of three antivenoms against medically significant Centruroides species. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2024).
2. Protein and peptide profiles of rats’ organs in scorpion envenomation. Toxicology Reports (2023).
3. Scorpion Peptides and Ion Channels: An Insightful Review of Mechanisms and Drug Development. Toxins (2023).
4. Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality. Nature Communications (2016).